XTalks

JANUARY 24, 2024

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.

Life Science 52

Life Science Clinical Research Drugs Development 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. A commercial-stage biopharmaceutical firm, Oyster Point discovers, develops and commercialises therapies for treating ophthalmic ailments.

Life Science 147

Life Science Sales Development Drugs 147

Pharmaceutical Technology

JULY 28, 2022

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.

Life Science 130

Life Science Marketing Production Research 130

Drug Discovery World

APRIL 17, 2024

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

Life Science 52

Life Science Clinical Research Marketing Development 52

Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

XTalks

FEBRUARY 14, 2024

This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 119

Life Science DNA Production Clinical Trials 119

XTalks

FEBRUARY 14, 2023

The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.

Life Science 98

Life Science Clinical Trials Clinical Trials Development 98

Pharmaceutical Technology

AUGUST 15, 2022

It is no secret that Canada boasts a strong and competitive life sciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge life sciences innovation. These factors have combined to make Ontario a leading force for medical research and innovation. Again, this is nothing new.

Life Science 130

Life Science Research Manufacturing Insulin 130

XTalks

JULY 5, 2023

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Development Engineer Scientist 97

pharmaphorum

DECEMBER 8, 2022

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

Life Science 103

Life Science Medicine Branding Research 103

Drug Discovery World

APRIL 17, 2024

The European Laboratory Research & Innovation Group (ELRIG) UK has entered into a partnership with SRG to support the advancement of science professionals in their careers. As part of the ELRIG events programme, there are a range of activities designed specifically for ECPs.

Life Science 52

Life Science Drugs Development Research 52

XTalks

JANUARY 20, 2022

Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Job Description.

Life Science 98

Life Science Production Marketing Big Data 98

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Anti-ageing science therefore has huge value.

Life Science 98

Life Science DNA Clinical Development Development 98

XTalks

SEPTEMBER 6, 2023

David Young, founder and President R&D at Processa Pharmaceuticals, a clinical-stage pharmaceutical company developing personalized approaches to cancer treatments with a focus on next generation chemotherapy drugs with improved safety and efficacy. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Drugs Development Research 116

Drug Discovery World

FEBRUARY 6, 2024

The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a UK government must do to make the country a great place to research and develop the medicines and vaccines of the future. The post The ABPI sets out a manifesto for UK life sciences appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Medicine Vaccination Vaccine 52

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. The company strengthens the translational research collaboration between the US and Ireland.

Development 259

Development Life Science Clinical Trials Clinical Trials 259

Drug Discovery World

MAY 16, 2024

million development in Manchester intended to enhance the city’s Oxford Road Corridor knowledge quarter as a hub for life sciences and technology innovation. Greenheys at Manchester Science Park is scheduled for completion in Summer 2026 and will span 131,000 sq ft across six floors. Work has started on a £60 ($75.1)

Biobanking 59

Biobanking Development Life Science Genome 59

XTalks

FEBRUARY 28, 2024

Ayesha spoke about how the Rare Disease Day campaign helps increase awareness about rare diseases, promotes research and development, supports advocacy for policies supporting patients and their families and brings together a global rare disease community. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Research Genetics Drugs 52

Drug Discovery World

OCTOBER 31, 2023

PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. According to the report, the life science industry represents a £43.4 ($52.7)

Life Science 52

Life Science Drugs Research Development 52

Drug Discovery World

MARCH 16, 2023

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? Investment zones The government confirmed plans for 12 low-tax ‘investment zones’ across the UK, with the aim of creating new business clusters focused around universities and research institutions.

Life Science 97

Life Science Regulation Medicine Research 97

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. billion in 2022.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

MAY 15, 2024

Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Prior to Ovid, she founded and led the Reputation & Risk Management Group, a consultancy within Syneos Health, one of the world’s largest clinical research organizations.

Life Science 69

Life Science Medicine Clinical Research Development 69

XTalks

JANUARY 10, 2024

Dr. Kaplin is a neuropsychiatrist whose research focuses on the investigation of the biological basis of immune-mediated depression and cognitive impairment by using multiple sclerosis as the model. Dr. Kaplin transitioned into industry by joining MIRA Pharmaceuticals to help lead drug development in the space.

Life Science 52

Life Science Development Drugs Medicine 52

Drug Discovery World

JULY 11, 2022

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US. . Awakn Life Sciences has developed a ketamine-assisted therapy programme for treating alcohol use disorder (AUD).

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

Pharma Times

AUGUST 3, 2022

The sites will maximise local and global benefits of NHS, research, industry and community partnerships

Life Science 113

Life Science Development Research 113

XTalks

APRIL 14, 2021

In this episode of the Xtalks Life Science Podcast, Sarah revisits two Parkinson’s biotech companies — Prevail Therapeutics and Voyager Therapeutics — to see what progress they’ve made in their gene therapy clinical development programs since April 2019. Parkinson’s and Melanoma Share an Amyloid Link, Says New Research.

Life Science 98

Life Science Gene Therapy Development Drugs 98

pharmaphorum

DECEMBER 21, 2022

Recent research also found that, as of 2022, the sector had one of the lowest proportions of Net Zero targets of all industries. Two-thirds – 67% – of life sciences companies surveyed had not set a Net Zero target in 2022. This should give the life sciences sector the confidence to tackle the sustainability challenges it faces.

Life Science 98

Life Science DNA Production Development 98

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development.

Development 311

Development Drugs Pharma Companies Life Science 311

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.

Life Science 105

Life Science Gene Therapy DNA Vaccination 105

Drug Discovery World

JULY 8, 2022

? Work has started on the first wholly speculative development of new multi-let laboratory and office space at Cambridge Biomedical Campus in the UK, which is specifically targeting a range of growing biotech and life science businesses. .

Life Science 52

Life Science Development Medicine Scientist 52

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? Dr Doina Ionescu (DI): After completing my PhD in physics at the University of Southampton, I joined Merck as a research scientist in 1998. DI: Transitioning from being a research scientist to a mergers & acquisitions project manager was not easy. What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

Drug Discovery World

AUGUST 4, 2023

Charles River Laboratories has revealed plans to open Charles River Accelerator and Development Lab (CRADL) locations in Seattle and Philadelphia, expanding the company’s contract vivarium space for the biopharmaceutical industry. Both Seattle and Philadelphia are emerging as cities with significant biopharmaceutical communities.

Life Science 52

Life Science Gene Therapy Gene Editing In-Vivo 52

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

Drug Discovery World

JUNE 14, 2023

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. To read all of the findings, access the full report here.

Life Science 52

Life Science Research Drugs Containment 52

Drug Discovery World

FEBRUARY 28, 2024

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Research into new cancer drugs remain strong.

Development 64

Development Research Drugs Antibody 64

BioTech 365

JANUARY 10, 2022

Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development NASHVILLE, Tenn.–(BUSINESS

Life Science 40

Life Science Genome Genomics Development 40

Drug Discovery World

MAY 10, 2023

PerkinElmer’s Life Sciences division has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The post PerkinElmer Life Sciences division becomes Revvity appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Reagent Genome Genomics 52